Pharma CEOs warn EC President of “risk of exodus” to US [Yahoo! Finance]
Novo Nordisk A/S (NVO)
Last novo nordisk a/s earnings: 2/5 01:31 am
Check Earnings Report
US:NYSE Investor Relations:
novonordisk.com/investors.html
Company Research
Source: Yahoo! Finance
In a meeting with European Commission (EC) President Ursula von der Leyen, the European Federation of Pharmaceutical Industries and Associations (EFPIA) called for urgent action to counter what it described as a “risk of exodus” in R&D and manufacturing. The group said that unless the EU rapidly reforms its regulatory, intellectual property, and investment environment, drugmakers will increasingly shift operations to the US. The issue is further complicated by recent US trade developments. Although the White House confirmed last week that finished pharmaceutical products are currently exempt from the recently imposed 10% blanket tariff , President Donald Trump stated on 3 April that new tariffs specifically targeting the pharma sector are on thei
Read more
Impact Snapshot
Event Time:
NVO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NVO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NVO alerts
High impacting Novo Nordisk A/S news events
Weekly update
A roundup of the hottest topics
NVO
News
- The $160 Billion Fund Behind Novo Nordisk Puts Investing on Hold [Yahoo! Finance]Yahoo! Finance
- Lawsuit alleges Maryland man with diabetes became blind after taking Ozempic [MSNBC.com]MSNBC.com
- Novo Nordisk scores major legal win that bars many compounded versions of Wegovy, Ozempic [MSNBC.com]MSNBC.com
- Novo Nordisk protects US patients with legal wins against compounders, including ruling that permanently prohibits compounding pharmacy from selling illegitimate, knockoff Wegovy® or Ozempic® [Yahoo! Finance]Yahoo! Finance
- Ozempic compounders suffer fresh setback as judge rejects injunction [Seeking Alpha]Seeking Alpha
NVO
Earnings
- 2/6/25 - Beat
NVO
Sec Filings
- 4/23/25 - Form SCHEDULE
- 4/3/25 - Form 6-K
- 3/31/25 - Form 6-K
- NVO's page on the SEC website